| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
CareDx (NASDAQ:CDNA) reported its Q3 earnings results on Wednesday, November 8, 2023 at 04:05 PM.
Here's what investors need to know about the announcement.
CareDx beat estimated earnings by 53.85%, reporting an EPS of $-0.18 versus an estimate of $-0.39.
Revenue was down $12.17 million from the same period last year.
Last quarter the company beat on EPS by $0.13 which was followed by a 11.23% drop in the share price the next day.
Here's a look at CareDx's past performance:
| Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.31 | -0.11 | -0.09 | -0.14 |
| EPS Actual | -0.18 | -0.11 | -0.07 | -0.06 |
| Revenue Estimate | 61.76M | 80.70M | 81.66M | 82.62M |
| Revenue Actual | 70.30M | 77.26M | 82.38M | 79.36M |
To track all earnings releases for CareDx visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: CDNA
